Skip to content
OpenCapital
Get started

Microbot Medical MBOT Q1 2025 earnings

Reported May 14, 2025 · Before market open

Diluted EPS-$0.08Beat by $0.05
EPS estimate-$0.13

Next report

Aug 11, 2026 (in a month)
Revenue estimate$583.3K
EPS estimate-$0.09

Financials

Q1 2025

Income statement

See full
Operating income-$3.0M-26.7%
Net income-$2.6M-9.7%
EPS (diluted)-$0.08+52.9%

Balance sheet

See full
Cash & equivalents$3.2M+177%
Total debt$138.0K-33.7%
Total equity$29.0M+369%
Total assets$30.9M+319%

Cash flow

See full
Operating cash flow-$2.9M-18.8%
CapEx$13.0K-7.1%
Free cash flow-$2.9M-18.6%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$52.46M+196%
Enterprise value$49.39M+195%

Returns & leverage

See full
Return on equity-66.5%-26.0pp
Debt / equity0×0.0×
Current ratio16.2×+10.3×

Versus estimates

Revenue

Q1 2026$105.0KMiss by $195.0K

Diluted EPS

Q1 2026-$0.05Beat by $0.03Q4 2025-$0.04Beat by $0.02Q3 2025-$0.07Miss by $0.01Q2 2025-$0.10Miss by $0.02
Q1 2025-$0.08Beat by $0.05
Q4 2024-$0.20Miss by $0.02

Ask the moment Microbot Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Microbot Medical report Q1 2025 earnings?
Microbot Medical (MBOT) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Microbot Medical's Q1 2025 revenue and EPS?
Microbot Medical reported diluted EPS of $-0.08 for Q1 2025.
Did Microbot Medical beat estimates in Q1 2025?
EPS beat the consensus estimate of $-0.13 by $0.05.
How did Microbot Medical's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 52.9% from $-0.17.
Where can I find Microbot Medical's Q1 2025 SEC filings?
You can read the 10-Q periodic report (0001641172-25-010277) directly on SEC EDGAR. The filing index links above go to sec.gov.